Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale President and CEO sold 3,805 shares at $3.35 ($12,753)
  9. 4 Planned sale EVP & Chief Medical Officer sold 6,770 shares at an average $4.05 ($27,416)
  10. 4 Planned sale President and CEO sold 3,497 shares at $3.97 ($13,883)
  11. 4 Open-market sale President and CEO sold 3,506 shares at $3.16 ($11,079)
  12. 4 Grant or award EVP & Chief Medical Officer acquired 100,000 shares (grant or award)
  13. 4 Grant or award EVP, Chief Development Officer acquired 95,000 shares (grant or award)
  14. 4 Open-market sale SVP, Chief Business Officer sold 6,357 shares at $3.03 ($19,257)
  15. 4 Open-market sale SVP, General Counsel&Secretary sold 6,878 shares at $3.03 ($20,835)
  16. 4 Open-market sale EVP & Chief Commercial Officer sold 11,239 shares at $3.03 ($34,045)
  17. 4 Open-market sale EVP, CFO & Treasurer sold 11,205 shares at $3.03 ($33,942)
  18. 4 Open-market sale President and CEO sold 33,033 shares at $3.03 ($100,064)
  19. 4 Open-market sale EVP, CFO & Treasurer sold 2,802 shares at $3.04 ($8,509)
  20. 4 Open-market sale EVP, Chief Development Officer sold 5,869 shares at an average $3.19 ($18,717)

Page 8 of 31 · 601 filings